Articles published by 23andMe, Inc.
Independent Directors of 23andMe Resign from Board
September 17, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All Populations
September 12, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024
September 03, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program
August 28, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe Reports First Quarter Fiscal 2025 Financial Results
August 08, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe Announces CEO’s Take-Private Proposal
August 01, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe to Report Q1 FY2025 Financial Results
July 25, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
June 28, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe Launches New Genetic Report on Bipolar Disorder
June 05, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history
May 29, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
March 20, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe Reports Third Quarter Fiscal 2024 Financial Results
February 07, 2024
From 23andMe, Inc.
Via GlobeNewswire
23andMe Announces FDA Clearance of IND Application for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
January 31, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay
January 30, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.